Shares of Echo Therapeutics Inc.plunged 17.3% to close at $1.48 on Jul 11, after the company announced that it has received a delisting notice from the Nasdaq stock market. The company announced that it expects to start trading on the OTCQB Venture Market, operated by the OTC Markets Group Inc. under its current trading symbol "ECTE" from Jul 12.
The delisting resulted from Echo Therapeutics' failure to comply with Nasdaq's minimum shareholder equity requirement.
The delisting resulted from Echo Therapeutics' failure to comply with Nasdaq's minimum shareholder equity requirement.
